Sign in
4

Changes in Ownership

Xenon Pharmaceuticals Inc. Filed Acc 0001171843-17-003443

Options or other derivatives

  • Director acquired 4,750 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

TARNOW MICHAEL M · Director

Table II: Derivative

2 lines
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2017-06-01 Grant or award : show line 1 in the form Stock Option (Right to Buy) +3,500 $3.85 2027-05-31 3,500 3,500 D
2017-06-01 Grant or award : show line 2 in the form Stock Option (Right to Buy) +1,250 $3.85 2027-05-31 1,250 1,250 D
Loading xslF345X03/formfour.xml…